Tandem Diabetes Care Statistics

Total Valuation

LON:0M0F has a market cap or net worth of GBP 769.27 million. The enterprise value is 865.19 million.

Market Cap	769.27M
Enterprise Value	865.19M

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	66.61M
Shares Outstanding	n/a
Shares Change (YoY)	+0.86%
Shares Change (QoQ)	+0.37%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	61.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.01
PB Ratio	6.40
P/TBV Ratio	6.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.08
EV / Sales	1.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-294.48

Financial Position

The company has a current ratio of 2.30, with a Debt / Equity ratio of 3.21.

Current Ratio	2.30
Quick Ratio	1.72
Debt / Equity	3.21
Debt / EBITDA	n/a
Debt / FCF	-131.22
Interest Coverage	-12.46

Financial Efficiency

Return on equity (ROE) is -92.31% and return on invested capital (ROIC) is -8.36%.

Return on Equity (ROE)	-92.31%
Return on Assets (ROA)	-6.17%
Return on Invested Capital (ROIC)	-8.36%
Return on Capital Employed (ROCE)	-14.50%
Revenue Per Employee	287,092
Profits Per Employee	-53,702
Employee Count	2,650
Asset Turnover	1.06
Inventory Turnover	3.18

Taxes

In the past 12 months, LON:0M0F has paid 7.30 million in taxes.

Income Tax	7.30M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.31% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-65.31%
50-Day Moving Average	20.37
200-Day Moving Average	27.90
Relative Strength Index (RSI)	31.45
Average Volume (20 Days)	933

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.15

Income Statement

In the last 12 months, LON:0M0F had revenue of GBP 760.79 million and -142.31 million in losses. Loss per share was -2.17.

Revenue	760.79M
Gross Profit	397.30M
Operating Income	-71.16M
Pretax Income	-135.01M
Net Income	-142.31M
EBITDA	-58.10M
EBIT	-71.16M
Loss Per Share	-2.17

Full Income Statement

Balance Sheet

The company has 285.31 million in cash and 385.53 million in debt, giving a net cash position of -100.21 million.

Cash & Cash Equivalents	285.31M
Total Debt	385.53M
Net Cash	-100.21M
Net Cash Per Share	n/a
Equity (Book Value)	120.19M
Book Value Per Share	1.81
Working Capital	290.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.79 million and capital expenditures -13.73 million, giving a free cash flow of -2.94 million.

Operating Cash Flow	10.79M
Capital Expenditures	-13.73M
Free Cash Flow	-2.94M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 52.22%, with operating and profit margins of -9.35% and -18.71%.

Gross Margin	52.22%
Operating Margin	-9.35%
Pretax Margin	-17.75%
Profit Margin	-18.71%
EBITDA Margin	-7.64%
EBIT Margin	-9.35%
FCF Margin	n/a

Dividends & Yields

LON:0M0F does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.86%
Shareholder Yield	n/a
Earnings Yield	-18.50%
FCF Yield	-0.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0M0F has an Altman Z-Score of 1.32 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.32
Piotroski F-Score	5